An interventional study of Post-exercise Recovery in Athletic Performance, Hyperbaric Oxygenation and Physical Endurance, sponsored by Université Catholique de Louvain. Recruiting at 1 site in Belgium. Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 47 studies in Fatigue with a site in Belgium — 10 open to participants now, 13 under way, 4 of them phase 3. Fatigue · Belgium.
Among the 47 studies in Fatigue with a site in Belgium, this one is the 19th largest by planned enrollment of the 34 interventional ones that give a count, is one of 5 that started in 2026, is one of 24 with no phase, reaches primary completion later than 10 of the 12 other live ones, and was the 44th registered.
2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.
Browse Fatigue studies →10 of the 47 studies in Fatigue with a site in Belgium are open now. Recruiting first, the newest first:
University Hospital, Ghent · Sites in Belgium
Ages 18+
Harmony Biosciences Management, Inc. · Sites in Belgium, United States, Canada and 4 more countries
Ages 18+
Alkermes, Inc. · Sites in Belgium, United States, Australia and 12 more countries
Ages 18–70
Vrije Universiteit Brussel · Sites in Belgium
Ages 18–35 · Healthy volunteers
Pfizer · Sites in Belgium, United States, Australia and 18 more countries
Ages 18+
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.
This study: 18 Years to 40 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
47 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 6 · Phase 4 3
First in 2005; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 48 is below the median of 54 across 1,762 interventional studies indexed under Fatigue.
Median enrollment 58 across the 34 interventional studies, 89 across the 13 observational. Of the 28 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 47 have an industry lead sponsor. The 10 most frequent:
Université Catholique de Louvain is the lead sponsor of 155 studies on the registry; 60 are open to participants now.
Université Catholique de Louvain has 1 study filed under Fatigue — fewer than ten, so there is no comparison to draw.
4 of the studies in Fatigue with a site in Belgium that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07455383Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 | 2027-05 |
| NCT07675135Phase 3Harmony Biosciences Management, Inc.A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy | 2027-10 |
| NCT07355101Universiteit AntwerpenPersonalized Exercise Coaching to Improve Quality of Life in Pediatric IBD | 2027-04-01 |
| NCT07840872Vrije Universiteit BrusselExploring the Effect of the Hypershell Hip Exoskeleton on Fatiguing, Everyday Activities in Older Adults | 2027-06 |
Add all 4 to your calendar (.ics) → With an account.
Among the 47 studies in Fatigue with a site in Belgium, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study examines whether exposition to hyperbaric oxygen after a road-race simulation can help competitive cyclists recover and perform better the following day.
Hyperbaric oxygen, which involves breathing oxygen inside a pressurized chamber, is used as a recovery method in elite and professional sport. Its effectiveness, however, remains controversial: despite this widespread use, there is a lack of solid scientific evidence that a single HBO session after strenuous endurance exercise actually improves recovery, or that clarifies how the amount of oxygen exposure influences any benefit.
The study includes healthy male road cyclists between 18 and 40 years of age who compete at the national level in Belgium. After completing a fatiguing cycling session, each participant is randomly assigned to one of four groups receiving different levels of oxygen exposure during recovery.
Two groups breathe oxygen under increased pressure inside a chamber at either 2.5 or 1.4 atmospheres absolute. A third group breathes oxygen at normal pressure. The fourth group receives a sham condition that reproduces the treatment setting without active oxygen exposure.
The study is double-blind, meaning that neither the participants nor the researchers assessing the outcomes know which condition each participant receives.
The main goal is to determine whether a single session of post-exercise HBO improves next-day endurance performance, and whether higher oxygen exposure produces greater effects.
The researchers also collect blood samples and physiological measurements to better understand how the body recovers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
PiO₂ = 2.5 (100 % O₂ x 2.5 ATA)
Other: Post-exercise Recovery
PiO₂ = 1.4 (100 % O₂ x 1.4 ATA)
Other: Post-exercise Recovery
PiO₂ = 1.0 (100 % O₂ x 1.0 ATA)
Other: Post-exercise Recovery
PiO₂ = 0.21 (21 % O₂ x 1.0 ATA)
Other: Post-exercise Recovery
1h intervention after a fatiguing exercise
Next-day endurance performance : Percent decrement in time to exhaustion from baseline
Endurance performance measured by a cycling time-to-exhaustion test at 105% of the lactate threshold power, expressed as the percentage decrement in time to exhaustion relative to the baseline test. Performance is compared SHAM to the other oxygen-exposure groups.
Time frame: Throughout the entire study, approximately during 18 months
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2026 (actual). Primary completion is estimated for Dec 2027, 17 months after the start.
Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 17 months is above that.
Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Université Catholique de Louvain →